InPen app recalled over software errors affecting insulin dose reminders
Medtronic is recalling the InPen App for iOS and Android because software design errors could lead to a missed short-acting insulin dose reminder and a recommendation to correct a high glucose value. 6,816 units are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported; a missed insulin dose reminder is a potential harm and no injuries are reported.
Plain-English summary
The InPen App, CFN MMT-8060 for iOS users and MMT-8061 for Android users, UDI-DI 0763000B000122075, is being recalled across software versions including 7.0.0, 7.1.0, 7.2.0 and 7.5.0. The recall covers 6,816 units distributed internationally, including Argentina, Australia, Austria, Belgium, Bermuda, Chile and the Czech Republic.
Medtronic MiniMed, Inc. is recalling the app because of software design errors that could lead to a missed short-acting insulin dose reminder and a recommendation to correct a high glucose value. The company states the issue does not affect insulin delivery, long-acting insulin dose reminders or CGM alerts, and that users can still use the pen itself to calculate a dose, deliver insulin and record the dose. The FDA classified the action as Class II.
Users should follow Medtronic's instructions for updating the app and continue to monitor glucose as directed by their clinician.
The recalled product
- Product
- InPen App, CFN: MMT-8060 (iOS Users) and MMT-8061 (Android Users)
- Manufacturer
- Medtronic MiniMed, Inc.
- Affected units
- 6,816
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- UDI-DI: 0763000B000122075 CFN/Software Version: MMT-8060/7.0.0
- 7.1.0
- 7.2.0 and 7.5.0 MMT-8061/7.0.0
- 7.0.1
- 7.1.1
- 7.2.0 and 7.5.0
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · Medtronic MiniMed, Inc.
See all →- HighMedtronic MiniMed 780G Insulin Pumps Recalled for Chemical Damage Risk
FDA (Devices) · 2026-08-26
- HighMedtronic MiniMed 640G Insulin Pumps Recalled for Chemical Damage Risk
FDA (Devices) · 2026-08-26
- SevereMedtronic MiniMed 670G Insulin Pumps Recalled Due to Chemical Damage Risk
FDA (Devices) · 2026-08-26
- HighMiniMed Go App Recalled Due to Missed Insulin Alerts
FDA (Devices) · 2026-07-29
- HighMiniMed 780G Insulin Pump Software Anomaly Recall
FDA (Devices) · 2026-07-15
Same hazard · software defect
See all →- HighMedos Velys Robotic-Assist Station Recalled for Software Movement Issue
FDA (Devices) · 2026-09-09
- HighBaxter Novum IQ Syringe Pump Software Issue Recall
FDA (Devices) · 2026-09-09
- HighBaxter Novum IQ Syringe Pump Recalled for Software Infusion Issue
FDA (Devices) · 2026-09-09
- HighMidmark IQecg Digital ECG Software Recall for Inaccurate Waveforms
FDA (Devices) · 2026-09-02
- HighMidmark Digital ECG Software Recall for Incorrect Waveform Display
FDA (Devices) · 2026-09-02